UK Clinical Nutrition For Cancer Care Market Size & Outlook

The clinical nutrition for cancer care market in UK is expected to reach a projected revenue of US$ 314.0 million by 2030. A compound annual growth rate of 3.3% is expected of UK clinical nutrition for cancer care market from 2024 to 2030.
Revenue, 2023 (US$M)
$249.9
Forecast, 2030 (US$M)
$314.0
CAGR, 2024 - 2030
3.3%
Report Coverage
UK

UK clinical nutrition for cancer care market, 2018-2030 (US$M)

UK

Related Markets

UK clinical nutrition for cancer care market highlights

  • The UK clinical nutrition for cancer care market generated a revenue of USD 249.9 million in 2023 and is expected to reach USD 314.0 million by 2030.
  • The UK market is expected to grow at a CAGR of 3.3% from 2024 to 2030.
  • In terms of segment, oral was the largest revenue generating product in 2023.
  • Enteral is the most lucrative product segment registering the fastest growth during the forecast period.


Clinical nutrition for cancer care market data book summary

Market revenue in 2023USD 249.9 million
Market revenue in 2030USD 314.0 million
Growth rate3.3% (CAGR from 2023 to 2030)
Largest segmentOral
Fastest growing segmentEnteral
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOral, Enteral, Parenteral
Key market players worldwideAbbott Laboratories, Pfizer Inc, Bayer AG, Nestle SA, GlaxoSmithKline, Baxter International Inc, Otsuka Holdings Co Ltd, Reckitt Benckiser Group PLC, Danone SA, Victus


Other key industry trends

  • In terms of revenue, UK accounted for 5.4% of the global clinical nutrition for cancer care market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany clinical nutrition for cancer care market is projected to lead the regional market in terms of revenue in 2030.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 398.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Nutrition For Cancer Care Market Companies

Name Profile # Employees HQ Website

UK clinical nutrition for cancer care market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical nutrition for cancer care market will help companies and investors design strategic landscapes.


Oral was the largest segment with a revenue share of 47.9% in 2023. Horizon Databook has segmented the UK clinical nutrition for cancer care market based on oral, enteral, parenteral covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to UK clinical nutrition for cancer care market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UK clinical nutrition for cancer care market databook

  • Our clientele includes a mix of clinical nutrition for cancer care market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UK clinical nutrition for cancer care market , including forecasts for subscribers. This country databook contains high-level insights into UK clinical nutrition for cancer care market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UK clinical nutrition cancer care market report size, by product, 2018-2030 (US$M)

UK Clinical Nutrition For Cancer Care Market Outlook Share, 2023 & 2030 (US$M)

UK clinical nutrition cancer care market report size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more